PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs ILMN |
|---|---|---|---|---|---|
| A | Agilent Technologies, Inc. | 2.05 | 29.8 | 14.5% | -76% |
| ISRG | Intuitive Surgical, Inc. | 2.06 | 44.4 | 21.5% | -76% |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.50 | 19.9 | 5.7% | -59% |
| VRTX | Vertex Pharmaceuticals Incorporated | 3.67 | 30.0 | 8.2% | -57% |
| TMO | Thermo Fisher Scientific Inc. | 15.80 | 31.5 | 2.0% | +84% |